SecurityATRS / Antares Pharma, Inc. (036642106)
Institutional Owners127 (20 N-Q Owners)
Institutional Shares57,899,387 - 36.93% (ex. N-Q)
Common Shares Outstanding156,788,986 shares (as of 2017-12-31)
Institutional Value$ 133,675,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Antares Pharma, Inc. (NASDAQ:ATRS) has 127 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 57,899,387 shares. Largest shareholders include Armistice Capital, Llc, BlackRock Inc., Vanguard Group Inc, Broadfin Capital, LLC, Perceptive Advisors Llc, FMR LLC / Fidelity, State Street Corp, JW Asset Management, LLC, Northern Trust Corp, and Wells Fargo & Company/mn.

Antares Pharma, Inc. (NASDAQ:ATRS) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-13 13F-HR AMALGAMATED BANK 18,326 19,203 4.79 59 38 -35.59
2018-02-13 13F-HR Legal & General Group Plc 37,389 37,389 0.00 121 75 -38.02
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 14,469 29,746 105.58 46,880 59,195 26.27
2017-11-03 13F-HR Asymmetry Capital Management, L.P. 199,655 0 -100.00 643 0 -100.00
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 0 16,100 0 32
2017-11-28 N-Q Usaa Mutual Funds Trust (see advisory)
2018-02-13 13F-HR Capital Advantage, Inc. 34,000 34,000 0.00 110 68 -38.18
2018-01-24 13F-HR SG Americas Securities, LLC 12,203 40,450 231.48 40 80 100.00
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-02-12 13F-HR JW Asset Management, LLC 1,671,956 1,878,323 12.34 5,417 3,738 -31.00
2018-03-01 N-Q World Funds Trust (see advisory)
2018-02-14 13F-HR MENTA CAPITAL LLC 91,482 0 -100.00 296 0 -100.00
2018-02-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 12,110 24
2018-02-09 13F-HR Baird Financial Group, Inc. 189,310 171,310 -9.51 613 341 -44.37
2018-02-14 13F-HR DEUTSCHE BANK AG\ 739,608 319,943 -56.74 2,395 635 -73.49
2018-02-09 13F-HR Virtu Financial LLC 58,575 117
2018-02-02 13F-HR US BANCORP \DE\ 0 10,000 0 20
2018-02-28 N-Q Rydex Series Funds (see advisory)
2018-02-06 13F-HR M&T BANK CORP 130,000 130,000 0.00 421 259 -38.48
2018-02-14 13F-HR PERCEPTIVE ADVISORS LLC 4,353,897 3,745,662 -13.97 14,107 7,454 -47.16
2017-11-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 79,477 0 -100.00 256 0 -100.00
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 121,500 141,800 16.71 394 282 -28.43
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 96,335 96,793 0.48 312 193 -38.14
2018-02-28 N-Q Rydex Dynamic Funds (see advisory)
2017-10-30 N-Q Oppenheimer Global Multi Strategies Fund (see advisory)
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 692,050 138,383 -80.00 1,965 275 -86.01
2018-02-14 13F-HR Cubist Systematic Strategies, LLC 53,713 107
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 94,041 41,433 -55.94 305 82 -73.11
2018-02-09 13F-HR RHUMBLINE ADVISERS 150,288 124,616 -17.08 487 248 -49.08
2017-10-24 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 6,000 0 -100.00 19 0 -100.00
2018-02-14 13F-HR WOLVERINE TRADING, LLC 22,147 0 -100.00 72 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC 58,295 10,130 -82.62 188 20 -89.36
2018-02-14 13F-HR Voya Investment Management LLC 65,073 65,073 0.00 211 129 -38.86
2018-03-01 N-Q Aqr Funds (see advisory)
2018-02-14 13F-HR Janney Montgomery Scott LLC 10,000 0 -100.00 32 0 -100.00
2018-02-12 13F-HR Brown Advisory Securities, LLC 275,000 275,000 0.00 891 547 -38.61
2018-02-14 13F-HR AVENIR CORP 351,685 291,597 -17.09 1,139 580 -49.08
2018-02-27 13F-HR Advisornet Financial, Inc 12,220 24
2018-04-18 13F-HR Creative Planning 13,500 13,500 0.00 27 30 11.11
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 15,778 29,614 87.69 51 58 13.73
2018-02-01 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 59,413 59,413 0.00 192 118 -38.54
2018-01-26 13F-HR PERKINS CAPITAL MANAGEMENT INC 366,000 252,000 -31.15 1,186 501 -57.76
2017-11-15 13F-HR WOLVERINE TRADING, LLC Put 21,800 0 -100.00 70 0 -100.00
2018-02-12 13F-HR Atlantic Trust Group, LLC 125,000 125,000 0.00 405 249 -38.52
2018-02-14 13F-HR National Planning Corp 12,900 0 -100.00 42 0 -100.00
2017-11-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 28,970 0 -100.00 93 0 -100.00
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 12,612 12,612 0.00 37 25 -32.43
2018-01-23 13F-HR Baystate Wealth Management LLC 1,397 1,397 0.00 5 3 -40.00
2018-02-21 13F-HR Hanson McClain, Inc. 200 200 0.00 1 0 -100.00
2018-02-15 13F-HR Bb&t Investment Services, Inc. 2,780 2,780 0.00 9 6 -33.33
2018-02-09 13F-HR Bank of New York Mellon Corp 536,125 545,786 1.80 1,738 1,086 -37.51
2018-02-14 13F-HR LPL Financial LLC 46,194 19,391 -58.02 150 39 -74.00
2018-02-06 13F-HR SFE Investment Counsel 60,000 60,000 0.00 194 119 -38.66
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 228,385 228,071 -0.14 740 454 -38.65
2018-02-14 13F-HR MORGAN STANLEY 830,309 793,598 -4.42 2,690 1,578 -41.34
2018-02-28 N-Q Gps Funds I (see advisory)
2018-02-16 SC 13G ARMISTICE CAPITAL, LLC 7,600,000 10,000,000 31.58
2018-02-13 13F-HR Renaissance Technologies LLC 2,783,991 599,769 -78.46 9,020 1,194 -86.76
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 36,900 49,600 34.42 120 99 -17.50
2018-02-14 13F-HR Stone Ridge Asset Management LLC 19,240 38
2018-02-14 13F-HR BARCLAYS PLC 136,338 46,751 -65.71 442 93 -78.96
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 367,147 357,978 -2.50 1,190 712 -40.17
2018-02-05 13F-HR First Eagle Investment Management, LLC 50,000 50,000 0.00 162 100 -38.27
2018-02-14 13F-HR PANAGORA ASSET MANAGEMENT INC 403,465 906,017 124.56 1,307 1,803 37.95
2018-02-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 0 43,950 0 87
2018-02-12 13F-HR CITIGROUP INC 452 39,447 8,627.21 1 78 7,700.00
2017-11-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 54,000 0 -100.00 174 0 -100.00
2018-02-13 13F-HR Allianz Asset Management AG 786,240 776,204 -1.28 2,547 1,545 -39.34
2018-02-14 13F-HR TWO SIGMA ADVISERS, LP 56,185 60,319 7.36 182 120 -34.07
2018-02-26 N-Q Allianz Funds Multi-strategy Trust (see advisory)
2018-02-14 13F-HR AQR CAPITAL MANAGEMENT LLC 147,094 171,839 16.82 477 342 -28.30
2018-04-18 13F-HR Sonora Investment Management, LLC 3,000 3,000 0.00 5,970 6,600 10.55
2018-02-13 SC 13G/A Broadfin Capital, LLC 12,971,093 4,535,647 -65.03
2018-02-14 13F-HR ProShare Advisors LLC 0 21,332 0 42
2018-02-07 13F-HR OPPENHEIMER & CO INC 51,600 25,600 -50.39 167 51 -69.46
2018-02-14 13F-HR TWO SIGMA INVESTMENTS LLC 455,720 0 -100.00 1,477 0 -100.00
2018-02-12 13F-HR Commonwealth Equity Services, Llc. 59,373 118
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 17,994 4,416 -75.46 59 9 -84.75
2018-02-14 13F-HR Advisor Group, Inc. 500 101,837 20,267.40 2 203 10,050.00
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 334,507 129,470 -61.30 1,084 257 -76.29
2018-02-12 13F-HR Veritable, L.P. 100,000 100,000 0.00 324 199 -38.58
2018-01-23 13F-HR FNY Managed Accounts LLC 800 0 -100.00 2 0 -100.00
2018-02-13 13F-HR MML INVESTORS SERVICES, LLC 42,400 30,900 -27.12 137 61 -55.47
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 560,936 606,829 8.18 1,818 1,208 -33.55
2017-11-13 13F-HR Marshall Wace North America L.P. 128,920 0 -100.00 387 0 -100.00
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 49,323 53,673 8.82 159 174 9.43
2018-01-24 13F-HR IFP Advisors, Inc 14,095 95 -99.33 46 0 -100.00
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2018-02-14 13F-HR ROYAL BANK OF CANADA 22,424 16,572 -26.10 73 33 -54.79
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 100,000 100,000 0.00 324 199 -38.58
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 64,700 22,500 -65.22 210 45 -78.57
2018-02-12 13F-HR PRINCIPAL FINANCIAL GROUP INC 24,784 76,650 209.27 80 152 90.00
2018-02-14 13F-HR Rubric Capital Management LP 324,076 0 -100.00 1,050 0 -100.00
2018-02-14 13F-HR UBS Group AG 12,758 14,986 17.46 41 30 -26.83
2018-04-10 13F-HR Chevy Chase Trust Holdings, Inc. 15,000 15,000 0.00 30 33 10.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 114,848 13,498 -88.25 372 27 -92.74
2018-02-13 13F-HR Pds Planning, Inc 12,000 24
2018-02-14 13F-HR Moore Capital Management, LP 200,000 140,000 -30.00 648 279 -56.94
2018-02-14 13F-HR HighTower Advisors, LLC 13,100 13,600 3.82 44 26 -40.91
2018-02-14 13F-HR VANGUARD GROUP INC 6,147,211 6,067,039 -1.30 19,917 12,073 -39.38
2018-02-14 13F-HR BlueCrest Capital Management Ltd 12,019 0 -100.00 39 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 1,700 19,400 1,041.18 6 39 550.00
2018-02-14 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 103,529 44,868 -56.66 335 89 -73.43
2018-01-29 13F-HR NewSquare Capital LLC 7,258 7,258 0.00 24 14 -41.67
2018-02-15 13F-HR Metlife Investment Advisors, Llc 18,820 37
2018-02-14 13F-HR/A-1 FULLER & THALER ASSET MANAGEMENT, INC. 730,600 554,000 -24.17 2,367 1,102 -53.44
2018-04-18 13F-HR Tiaa, Fsb 491,130 491,000 -0.03 977 1,080 10.54
2018-02-15 13F-HR/A-1 Sabby Management, LLC Call 1,016 0 -100.00 329 0 -100.00
2017-11-14 13F-HR KINGDON CAPITAL MANAGEMENT, L.L.C. 946,987 0 -100.00 3,049 0 -100.00
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-05 13F-HR THOMPSON DAVIS & CO., INC. 112,768 0 -100.00 365 0 -100.00
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 1,309,831 1,283,758 -1.99 4,243 2,554 -39.81
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 8,760 8,260 -5.71 28 16 -42.86
2017-11-22 N-Q Quantitative Master Series Llc (see advisory)
2018-02-13 13F-HR JP Morgan Chase & Co 0 70,810 0 141
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 22,218 44
2018-02-14 13F-HR TEACHERS ADVISORS INC 257,124 257,124 0.00 833 512 -38.54
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 1,335,906 1,591,407 19.13 4,328 3,168 -26.80
2018-02-01 13F-HR Nationwide Fund Advisors 80,791 0 -100.00 262 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 500 15,257 2,951.40 2 30 1,400.00
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-14 13F-HR Krilogy Financial LLC 2,500 2,500 0.00 8 5 -37.50
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 5 10 100.00 0 0
2018-02-13 13F-HR PRUDENTIAL FINANCIAL INC 41,940 14,270 -65.98 136 28 -79.41
2018-02-09 13F-HR Banco BTG Pactual S.A. 11,298 0 -100.00 37 0 -100.00
2018-02-14 13F-HR ZEKE CAPITAL ADVISORS, LLC 10,811 22
2017-11-07 13F-HR Carl Domino Inc 32,500 32,500 0.00 105 105 0.00
2017-10-27 N-Q Stone Ridge Trust (see advisory)
2018-02-13 13F-HR Oak Asset Management, Llc 10,000 20
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 97,372 10,696 -89.02 315 21 -93.33
2018-02-15 13F-HR JANE STREET GROUP, LLC 11,254 26,569 136.08 19 53 178.95
2018-04-16 13F-HR SII INVESTMENTS INC/WI 15,800 0 -100.00 32 0 -100.00
2017-11-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 100,330 0 -100.00 323 0 -100.00
2018-02-14 13F-HR RAYMOND JAMES & ASSOCIATES 11,323 11,323 0.00 37 23 -37.84
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 15 2 -86.67 0 0
2018-02-02 13F-HR Ballentine Partners, LLC 100,000 100,000 0.00 324 199 -38.58
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 180,666 148,046 -18.06 360 326 -9.44
2018-02-12 13F-HR FMR LLC / Fidelity 2,913,687 2,580,900 -11.42 9,440 5,136 -45.59
2018-02-14 13F-HR A.R.T. Advisors, LLC 14,014 189,627 1,253.13 45 377 737.78
2017-10-26 13F-HR Acrospire Investment Management LLC 5,250 0 -100.00 17 0 -100.00
2018-02-14 13F-HR TWO SIGMA SECURITIES, LLC 16,633 0 -100.00 54 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 20,500 14,000 -31.71 66 28 -57.58
2017-11-08 13F-HR EAM Investors, LLC 251,619 0 -100.00 810 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 1,200 6,900 475.00 4 14 250.00
2018-02-01 SC 13G BlackRock Inc. 2,873,056 9,340,209 225.10
2017-11-29 N-Q Deutsche Investments Vit Funds (see advisory)
2018-02-27 N-Q Northern Funds (see advisory)
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2018-02-14 13F-HR Invesco Ltd. 49,914 51,758 3.69 162 103 -36.42
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 972,694 805,200 -17.22 3,152 1,602 -49.18
2018-04-17 13F-HR Calton & Associates, Inc. 3,500 0 -100.00 7 0 -100.00
2018-02-14 13F-HR STATE STREET CORP 2,636,856 2,449,128 -7.12 8,544 4,873 -42.97
2018-02-15 13F-HR/A-1 Sabby Management, LLC Put 227 0 -100.00 74 0 -100.00
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 119,903 118,846 -0.88 389 237 -39.07
2018-02-14 13F-HR Natixis 17,901 0 -100.00 58 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 16,613 0 -100.00 53 0 -100.00
2018-02-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 13,202 26
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 182,075 228,500 25.50 590 455 -22.88
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 408,944 631,049 54.31 1,326 1,255 -5.35
2018-02-14 13F-HR NORTHERN TRUST CORP 1,628,295 1,616,011 -0.75 5,276 3,216 -39.04

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( ATRS / Antares Pharma, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

ATRS : Antares Pharma Stock Analysis and Research Report

2017-10-31 - Asif

Antares Pharma, Inc. is an emerging, specialty pharmaceutical company that focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its strategy is to identify new or existing approved drug formulations and apply its drug delivery technology to enhance the drug compounds and delivery methods. The company develop, manufacture and commercialize, for itself or with partners, novel therapeutic products using its advanced drug delivery systems that are designed to help improve safety and efficacy, reduce side effects, and enhance patient comfort and adherence. Its subcutaneous injection technology platforms include the VIBEX® pressure-assisted auto injector system suitable for branded and generic injectable drugs in unit dose containers, reusable needle-free spring-action injector devices, and disposable multi-dose pen injectors for use with standard cartridges. Antares Pharma has a portfolio of proprietary and partnered pro...

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 036642106